Objective:
To evaluate the effectiveness of suprachoroidal triamcinolone in reducing retinal fluid and central subfield thickness in eyes undergoing complex retinal detachment repairs.
Approach:
- Suprachoroidal triamcinolone resulted in a mean CST reduction of 375 µm at approximately 6 weeks.
- Dexamethasone implants produced a mean CST reduction of 69 µm.
- Subtenon triamcinolone showed little improvement, with mean CST increasing by approximately 75 µm.
- Most eyes with isolated subretinal fluid required only a single injection of suprachoroidal triamcinolone.
- The study is retrospective and may have inherent biases.
- Exclusion of eyes treated for hypotony may limit generalizability.
Key Findings:
Interpretation:
The suprachoroidal approach may enhance drug distribution to the affected retinal pigment epithelium and choroidal tissues.
Limitations:
Conclusion:
Suprachoroidal triamcinolone shows promise as a targeted therapy for postoperative macular edema following complex retinal detachment repair.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.